Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y-A Que

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care UnitA Fournier, P Eggimann, O Pantet, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2018
Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"A Fournier, P Eggimann, O Pantet, et al.
Infection and Immunity|November 18, 2000
Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cellsB Sinha, P Francois, Y A Que, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 6, 2016
Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn traumaA Fournier, P Voirol, M Krähenbühl, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2019
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort studyL Boschung-Pasquier, A Atkinson, L K Kastner, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 27, 2014
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumoniaY-A Que, H Lazar, M Wolff, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care UnitA Fournier, P Eggimann, O Pantet, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2018
Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"A Fournier, P Eggimann, O Pantet, et al.
Infection and Immunity|November 18, 2000
Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cellsB Sinha, P Francois, Y A Que, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 6, 2016
Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn traumaA Fournier, P Voirol, M Krähenbühl, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2019
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort studyL Boschung-Pasquier, A Atkinson, L K Kastner, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 27, 2014
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumoniaY-A Que, H Lazar, M Wolff, et al.
Pageof 2